Chinese herbal medicine Dengzhan Xixin injection for acute ischemic stroke: A systematic review and meta-analysis of randomised controlled trials

• Published in: Complementary therapies in medicine Vol. 34; pp. 74 - 85
• Main Authors: Li, Jin-gen, Wang, Li-qiong, Yang, Xiao-ying, Chen, Zhuo, Lai, Lily Y.W., Xu, Hao, Liu, Jian-ping
• Format: Journal Article
• Language: English
• Published: Scotland Elsevier Ltd 01.10.2017; Elsevier Limited
• Subjects: Acute ischemic stroke; Adverse events; Aged; Aged, 80 and over; Anticoagulants; Bias; Brain; Brain Ischemia - complications; Brain Ischemia - drug therapy; Chinese herbal medicine; Clinical trials; Dengzhan xixin; Drug dosages; Drugs, Chinese Herbal - therapeutic use; Erigeron; FDA approval; Female; Herbal medicine; Humans; Injection; Injections; Ischemia; Kinases; Male; Meta-analysis; Middle Aged; Palliative care; Performance evaluation; Phytotherapy; Quality assessment; Quality of life; Randomised controlled trials; Software; Stroke; Stroke - drug therapy; Stroke - etiology; Systematic review; China; RR; NIHSS; NFDS; Randomised controlled trials; CI; BI; Dengzhan xixin; Systematic review; Meta-analysis; CT; Acute ischemic stroke; DZXX; MD; Chinese herbal medicine; vs

•The effectiveness and safety of DZXX injection for AIS was analysed.•It appears that DZXX can additionally improve neurological function for AIS patients.•The addition of DZXX injection to CT appears to be safe for patients with AIS.•More large, rigorous and adequately reported trials are needed to...